Repository logo
 

Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans.

Published version
Peer-reviewed

Loading...
Thumbnail Image

Change log

Authors

Rostami Kandroodi, Mojtaba  ORCID logo  https://orcid.org/0000-0002-5508-1421

Abstract

BACKGROUND: The non-selective serotonin 2A (5-HT2A) receptor agonist lysergic acid diethylamide (LSD) holds promise as a treatment for some psychiatric disorders. Psychedelic drugs such as LSD have been suggested to have therapeutic actions through their effects on learning. The behavioural effects of LSD in humans, however, remain incompletely understood. Here we examined how LSD affects probabilistic reversal learning (PRL) in healthy humans. METHODS: Healthy volunteers received intravenous LSD (75 μg in 10 mL saline) or placebo (10 mL saline) in a within-subjects design and completed a PRL task. Participants had to learn through trial and error which of three stimuli was rewarded most of the time, and these contingencies switched in a reversal phase. Computational models of reinforcement learning (RL) were fitted to the behavioural data to assess how LSD affected the updating ('learning rates') and deployment of value representations ('reinforcement sensitivity') during choice, as well as 'stimulus stickiness' (choice repetition irrespective of reinforcement history). RESULTS: Raw data measures assessing sensitivity to immediate feedback ('win-stay' and 'lose-shift' probabilities) were unaffected, whereas LSD increased the impact of the strength of initial learning on perseveration. Computational modelling revealed that the most pronounced effect of LSD was the enhancement of the reward learning rate. The punishment learning rate was also elevated. Stimulus stickiness was decreased by LSD, reflecting heightened exploration. Reinforcement sensitivity differed by phase. CONCLUSIONS: Increased RL rates suggest LSD induced a state of heightened plasticity. These results indicate a potential mechanism through which revision of maladaptive associations could occur in the clinical application of LSD.

Description

Journal Title

Psychol Med

Conference Name

Journal ISSN

0033-2917
1469-8978

Volume Title

Publisher

Cambridge University Press (CUP)

Rights and licensing

Except where otherwised noted, this item's license is described as Attribution 4.0 International
Sponsorship
Medical Research Council (MC_PC_17213)
Medical Research Council (MR/W014386/1)
Wellcome Trust (104631/Z/14/Z)
This study was funded by the Walacea.com crowdfunding campaign and the Beckley Foundation, awarded to R.L.C-H. J.W.K. was supported by a Gates Cambridge Scholarship and an Angharad Dodds John Bursary in Mental Health and Neuropsychiatry, T.W.R. by a Wellcome Trust Senior Investigator Grant 104631/Z/14/Z, and H.E.M.d.O. by the Netherlands Organisation for Scientific Research, NWO. R.N.C.’s research is funded by the UK Medical Research Council (MC_PC_17213, MR/W014386/1). Q.L. was partially sup- ported by grants from the National Key Research and Development Program of China (No. 2019YFA0709502), the National Natural Science Foundation of China (No. 81873909), the Science and Technology Commission of Shanghai Municipality (No.s 20ZR1404900 and 20DZ2260300), the Shanghai Municipal Science and Technology Major Project (No.s 2018SHZDZX01 and 2021SHZDZX0103), and the Fundamental Research Funds for the Central Universities. During the prepar- ation of this manuscript, Q.L. was a Visiting Fellow at Clare Hall, University of Cambridge, Cambridge, UK. This research was supported in part by the UK National Health Service (NHS) National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre (BRC-1215-20014); the views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care.

Relationships

Is derived from: